These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. Mirza R; Sharma B Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127 [TBL] [Abstract][Full Text] [Related]
23. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Bambini-Junior V; Rodrigues L; Behr GA; Moreira JC; Riesgo R; Gottfried C Brain Res; 2011 Aug; 1408():8-16. PubMed ID: 21767826 [TBL] [Abstract][Full Text] [Related]
24. Twenty years of discoveries emerging from mouse models of autism. Crawley JN Neurosci Biobehav Rev; 2023 Mar; 146():105053. PubMed ID: 36682425 [TBL] [Abstract][Full Text] [Related]
25. Mining and modeling human genetics for autism therapeutics. Smith DG; Ehlers MD Curr Opin Neurobiol; 2012 Oct; 22(5):902-10. PubMed ID: 22483267 [TBL] [Abstract][Full Text] [Related]
26. Autistic-like traits in laboratory rodents exposed to phthalic acid esters during early development - an animal model of autism? Morová M; Kršková L Physiol Res; 2021 Jul; 70(3):345-361. PubMed ID: 33982578 [TBL] [Abstract][Full Text] [Related]
27. Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism. Karvat G; Kimchi T Neuropsychopharmacology; 2014 Mar; 39(4):831-40. PubMed ID: 24096295 [TBL] [Abstract][Full Text] [Related]
34. Gestational/perinatal chlorpyrifos exposure is not associated with autistic-like behaviors in rodents. Williams AL; DeSesso JM Crit Rev Toxicol; 2014 Jul; 44(6):523-34. PubMed ID: 24861450 [TBL] [Abstract][Full Text] [Related]
35. Intact and impaired executive abilities in the BTBR mouse model of autism. Rutz HL; Rothblat LA Behav Brain Res; 2012 Sep; 234(1):33-7. PubMed ID: 22677272 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder. Kabitzke PA; Brunner D; He D; Fazio PA; Cox K; Sutphen J; Thiede L; Sabath E; Hanania T; Alexandrov V; Rasmusson R; Spooren W; Ghosh A; Feliciano P; Biemans B; Benedetti M; Clayton AL Genes Brain Behav; 2018 Jan; 17(1):4-22. PubMed ID: 28753255 [TBL] [Abstract][Full Text] [Related]
37. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders. Prem S; Millonig JH; DiCicco-Bloom E Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146 [TBL] [Abstract][Full Text] [Related]
39. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Schneider T; Przewłocki R Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991 [TBL] [Abstract][Full Text] [Related]
40. Autism-like behavior in the BTBR mouse model of autism is improved by propofol. Cai Y; Wang L; Xiao R; Li X; He X; Gao J; Xu H; Fan X Neuropharmacology; 2017 May; 118():175-187. PubMed ID: 28341205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]